Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Canagliflozin (November 2013)
    René Rodríguez-Gutiérrez, MD and Gloria Gonzalez-Saldivar, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87-88; DOI: https://doi.org/10.3949/ccjm.81c.02003

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • You have access
    Return of the ‘pisse-mongers,’ this time with data
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.81b.01014

    Urinalysis may be the oldest surviving laboratory test. Both Hippocrates and Galen recognized its value.

  • You have access
    How to spot heritable breast cancer: A primary care physician’s guide
    Marissa Smith, MS, CGC, Jessica Mester, MS, CGC and Charis Eng, MD, PhD
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 31-40; DOI: https://doi.org/10.3949/ccjm.81a.13051

    Because breast cancer is common, primary care physicians will encounter many patients who have a personal or family history of it. Many patients may benefit from referral to a cancer genetics program for assessment, genetic counseling, and consideration of genetic testing. This article discusses the complexities of risk assessment in cancer genetics (focusing on breast cancer), and highlights the primary care physician’s role in identifying and caring for patients at risk.

  • You have access
    Do all hospitalized patients need stress ulcer prophylaxis?
    Naseem Eisa, MD, Fateh Bazerbachi, MD, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 23-25; DOI: https://doi.org/10.3949/ccjm.81a.13070

    No. Only critically ill patients who meet specific criteria should receive it.

  • You have access
    Deep T waves and chest pain
    M. Chadi Alraies, MD, Wael Aljaroudi, MD, Usman Ayub Khan, MBBS and Abdul Hamid Alraiyes, MD
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 21-22; DOI: https://doi.org/10.3949/ccjm.81a.12176

    After 3 hours of chest pain, a 67-year-old man presented with deep symmetric T-wave inversions in the precordial leads, a prognostically significant finding.

  • New cholesterol guidelines: Worth the wait?
    You have access
    New cholesterol guidelines: Worth the wait?
    Chad Raymond, DO, Leslie Cho, MD, Michael Rocco, MD and Stanley L. Hazen, MD, PhD
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 11-19; DOI: https://doi.org/10.3949/ccjm.81a.13161

    An appraisal of the controversial new guidelines, with case scenarios illustrating their advantages and shortcomings.

  • You have access
    Obesity in the elderly: More complicated than you think
    Derrick C. Cetin, DO and Gaelle Nasr, BA
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 51-61; DOI: https://doi.org/10.3949/ccjm.81a.12165

    The number of obese older adults is on the rise, although we lack a proper definition of obesity in this age group. The ambiguity is primarily related to sarcopenia, the progressive loss of muscle and gain in fat that come with aging. Whether to treat and how to treat obesity in the elderly is controversial because of a paucity of established guidelines, but also because of the obesity paradox—ie, the apparently protective effect of obesity in this age group.

  • You have access
    Albuminuria: When urine predicts kidney and cardiovascular disease
    Reejis Stephen, MD, SM, Stacey E. Jolly, MD, MAS, Joseph V. Nally, MD and Sankar D. Navaneethan, MD, MPH
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 41-50; DOI: https://doi.org/10.3949/ccjm.81a.13040

    Albuminuria is common. Traditionally considered a precursor to diabetic nephropathy, it has now been directly linked to adverse cardiovascular outcomes and death, independent of other risk factors. In this review, we compare the measures of albuminuria, examine the evidence linking it to renal failure, cardiovascular disease, and death, and provide recommendations for its testing and management.

  • You have access
    An 85-year-old with muscle pain
    David Snipelisky, MD and Fernando Stancampiano, MD
    Cleveland Clinic Journal of Medicine January 2014, 81 (1) 27-30; DOI: https://doi.org/10.3949/ccjm.81a.13086

    When preventive therapy causes side effects, physicians face a dilemma.

  • You have access
    Third universal definition of myocardial infarction: Update, caveats, differential diagnoses
    David M. Tehrani, MS and Arnold H. Seto, MD, MPA
    Cleveland Clinic Journal of Medicine December 2013, 80 (12) 777-786; DOI: https://doi.org/10.3949/ccjm.80a.12158

    Troponin levels are elevated in nearly everyone having a myocardial infarction—but also in many who are not. Hence, clinical judgment is needed.

Pages

  • Previous
  • Next
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire